Orthopedic Roundup Q4: S&N, Stryker, J&J, Zimmer Biomet See Pandemic-Related Sales Impact
Executive Summary
The resurgence of the pandemic during the fourth quarter of 2020 led to slowdown in elective procedures, negatively impacting sales of the four big ortho players.
You may also be interested in...
Orthopedic Roundup Q1: COVID-19’s Stranglehold On Ortho Devices Begins To Loosen
J&J, Smith & Nephew, Stryker, Zimmer Biomet and other companies in the orthopedic and spine surgery space have welcomed a recent rebound in orthopedic device demand, but the volume of elective knee surgeries is still behind its pre-pandemic level.
Zimmer Biomet Receives 510(k) Clearance For ROSA Partial Knee System
The ROSA Partial Knee is part of Zimmer Biomet’s connected intelligence suite, which provides key analytics to health providers throughout a patient’s care continuum.
Italian Orthopedics Company Greenbone OrthoSpA Raises €10M In Series B
Greenbone will use the proceeds to launch its CE-marked bone regeneration scaffold and plans to file for 510(k) FDA clearance.